Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PF-06952229 |
Trade Name | |
Synonyms | PF06952229|PF 06952229 |
Drug Descriptions |
PF-06952229 is an inhibitor of the transforming growth factor-beta receptor 1 (TGFBR1), which results in stimulation of the immune system (NCI Drug Dictionary). |
DrugClasses | TGFBR1 inhibitor 16 |
CAS Registry Number | NA |
NCIT ID | C160258 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Enzalutamide + PF-06952229 | Enzalutamide PF-06952229 | 0 | 1 |
Letrozole + Palbociclib + PF-06952229 | Letrozole PF-06952229 Palbociclib | 0 | 1 |
PF-06952229 | PF-06952229 | 0 | 1 |